Prof. Cyrille Cohen – Fast Image-Guided Stratification Using Anti- Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy

Abstract Cancer immunotherapy has made enormous progress in offering safer and more effective treatments for the disease. Specifically, programmed death ligand 1 antibody (αPDL1), designed to perform immune checkpoint blockade (ICB), is now considered a pillar in cancer immunotherapy. However, due to the complexity and heterogeneity of tumors, as well as the diversity in patient…

Read More